Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 24, 2021

SELL
$74.77 - $85.47 $82,247 - $94,017
-1,100 Reduced 73.33%
400 $31,000
Q4 2020

Jan 15, 2021

BUY
$72.61 - $90.2 $79,653 - $98,949
1,097 Added 272.21%
1,500 $132,000
Q3 2020

Oct 21, 2020

SELL
$71.87 - $131.03 $21,489 - $39,177
-299 Reduced 42.59%
403 $31,000
Q2 2020

Jul 10, 2020

BUY
$79.55 - $124.22 $8,114 - $12,670
102 Added 17.0%
702 $87,000
Q1 2020

Apr 15, 2020

SELL
$71.37 - $96.85 $570 - $774
-8 Reduced 1.32%
600 $51,000
Q4 2019

Jan 22, 2020

SELL
$64.27 - $86.37 $64 - $86
-1 Reduced 0.16%
608 $51,000
Q3 2019

Oct 25, 2019

SELL
$67.4 - $85.11 $13,480 - $17,022
-200 Reduced 24.72%
609 $41,000
Q1 2019

Apr 29, 2019

BUY
$84.2 - $98.62 $17,597 - $20,611
209 Added 34.83%
809 $72,000
Q4 2018

Feb 04, 2019

BUY
$80.14 - $106.07 $48,084 - $63,641
600 New
600 $51,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.